Skip to main content
AAN.com
Articles
March 1, 1987

Positron emission tomography and histopathology in Pick's disease

March 1987 issue
37 (3) 439

Abstract

PET using 18F-2-fluoro-2-deoxyglucose was carried out on a case of Pick's disease established by necropsy. A sharply decreased cortical metabolic rate for glucose was obtained in specific gyri, especially in the frontal lobes, where there was extensive gliosis and neuronal loss. More moderate decreases were found in areas with numerous Pick bodies and inflated neurons but less gliosis. The PET pattern was sufficiently distinctive to suggest that it might be possible to distinguish Pick's from Alzheimer's disease premortem.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 37Number 3March 1987
Pages: 439
PubMed: 3493451

Publication History

Published online: March 1, 1987
Published in print: March 1987

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

H. Kamo, MD, PhD
Kinsmen Laboratory of Neurological Research (Drs. Kamo, P.L. McGeer, and E.G. McGeer), the Departments of Medicine (Drs. Calne and Martin) and Psychiatry (Drs. Kamo, P.L. McGeer, and E.G. McGeer), Faculty of Pharmaceutical Sciences (Dr. Pate), The UBC/TRIUMF Program on Positron Emission Tomography (Drs. Harrop and Pate), University of British Columbia, Vancouver, and the School of Computing Science (Dr. Harrop), Simon Fraser University, Burnaby, British Columbia, Canada.
P. L. McGeer, MD, PhD
Kinsmen Laboratory of Neurological Research (Drs. Kamo, P.L. McGeer, and E.G. McGeer), the Departments of Medicine (Drs. Calne and Martin) and Psychiatry (Drs. Kamo, P.L. McGeer, and E.G. McGeer), Faculty of Pharmaceutical Sciences (Dr. Pate), The UBC/TRIUMF Program on Positron Emission Tomography (Drs. Harrop and Pate), University of British Columbia, Vancouver, and the School of Computing Science (Dr. Harrop), Simon Fraser University, Burnaby, British Columbia, Canada.
R. Harrop, PhD
Kinsmen Laboratory of Neurological Research (Drs. Kamo, P.L. McGeer, and E.G. McGeer), the Departments of Medicine (Drs. Calne and Martin) and Psychiatry (Drs. Kamo, P.L. McGeer, and E.G. McGeer), Faculty of Pharmaceutical Sciences (Dr. Pate), The UBC/TRIUMF Program on Positron Emission Tomography (Drs. Harrop and Pate), University of British Columbia, Vancouver, and the School of Computing Science (Dr. Harrop), Simon Fraser University, Burnaby, British Columbia, Canada.
E. G. McGeer, PhD
Kinsmen Laboratory of Neurological Research (Drs. Kamo, P.L. McGeer, and E.G. McGeer), the Departments of Medicine (Drs. Calne and Martin) and Psychiatry (Drs. Kamo, P.L. McGeer, and E.G. McGeer), Faculty of Pharmaceutical Sciences (Dr. Pate), The UBC/TRIUMF Program on Positron Emission Tomography (Drs. Harrop and Pate), University of British Columbia, Vancouver, and the School of Computing Science (Dr. Harrop), Simon Fraser University, Burnaby, British Columbia, Canada.
D. B. Calne, MB, BS, FRCP
Kinsmen Laboratory of Neurological Research (Drs. Kamo, P.L. McGeer, and E.G. McGeer), the Departments of Medicine (Drs. Calne and Martin) and Psychiatry (Drs. Kamo, P.L. McGeer, and E.G. McGeer), Faculty of Pharmaceutical Sciences (Dr. Pate), The UBC/TRIUMF Program on Positron Emission Tomography (Drs. Harrop and Pate), University of British Columbia, Vancouver, and the School of Computing Science (Dr. Harrop), Simon Fraser University, Burnaby, British Columbia, Canada.
W. R. W. Martin, MD, FRCPC
Kinsmen Laboratory of Neurological Research (Drs. Kamo, P.L. McGeer, and E.G. McGeer), the Departments of Medicine (Drs. Calne and Martin) and Psychiatry (Drs. Kamo, P.L. McGeer, and E.G. McGeer), Faculty of Pharmaceutical Sciences (Dr. Pate), The UBC/TRIUMF Program on Positron Emission Tomography (Drs. Harrop and Pate), University of British Columbia, Vancouver, and the School of Computing Science (Dr. Harrop), Simon Fraser University, Burnaby, British Columbia, Canada.
B. D. Pate, PhD
Kinsmen Laboratory of Neurological Research (Drs. Kamo, P.L. McGeer, and E.G. McGeer), the Departments of Medicine (Drs. Calne and Martin) and Psychiatry (Drs. Kamo, P.L. McGeer, and E.G. McGeer), Faculty of Pharmaceutical Sciences (Dr. Pate), The UBC/TRIUMF Program on Positron Emission Tomography (Drs. Harrop and Pate), University of British Columbia, Vancouver, and the School of Computing Science (Dr. Harrop), Simon Fraser University, Burnaby, British Columbia, Canada.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Behavioral Variant Frontotemporal Dementia, Hybrid PET/MR Neuroimaging, (303-312), (2021).https://doi.org/10.1007/978-3-030-82367-2_26
    Crossref
  2. Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study, Journal of Nuclear Medicine, 61, 12, (1814-1819), (2020).https://doi.org/10.2967/jnumed.119.240325
    Crossref
  3. “Where is Dementia?” A Systematic Literature Review Exploring Neuroanatomical Aspects of Dementia, Perspectives of the ASHA Special Interest Groups, 2, 15, (9-23), (2017).https://doi.org/10.1044/persp2.SIG15.9
    Crossref
  4. Neuroradiologia funzionale del cervello, Rivista di Neuroradiologia, 6, 2, (129-138), (2016).https://doi.org/10.1177/197140099300600203
    Crossref
  5. Cerebral Blood Flow and Metabolism in Late-Life Depression and Dementia, Journal of Geriatric Psychiatry and Neurology, 12, 3, (118-127), (2016).https://doi.org/10.1177/089198879901200305
    Crossref
  6. Frontotemporal Hypometabolism in Amyotrophic Lateral Sclerosis‐Dementia Complex, Journal of Neuroimaging, 3, 4, (234-241), (2016).https://doi.org/10.1111/jon199334234
    Crossref
  7. Single‐Photon Emission Computed Tomographic Perfusion Imaging in Autopsy‐Diagnosed Dementia, Journal of Neuroimaging, 3, 2, (93-99), (2016).https://doi.org/10.1111/jon19933293
    Crossref
  8. Introduction to and brief history of FTD, Hodges' Frontotemporal Dementia, (1-29), (2016).https://doi.org/10.1017/CBO9781316091586.004
    Crossref
  9. Neurologische und dementielle Erkrankungen, PET/CT-Atlas, (765-794), (2016).https://doi.org/10.1007/978-3-662-48842-3_24
    Crossref
  10. SPECT for Differential Diagnosis of Dementia and Correlation of rCBF with Cognitive Impairment, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 21, 2, (104-111), (2015).https://doi.org/10.1017/S0317167100049015
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Figures

Tables

Media

Share

Share

Share article link

Share